Mon. 13 May 2024, 2:02pm ET
Benzinga
Biotech, General
Cognition Therapeutics To Be Issued US patent Number 11,981,636 Titled "COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISEASES (INCLUDING ALZHEIMER'S DISEASE AND COGNITIVE DECLINE)"
Company Profile